J
Meng, Jun
L
Meng, Lin
X
Meng, Xianlan
Y
Meng, Yajuan, Ning County Maternal and Child Health Hospital, Qingyang 745200, Gansu Province, China
Meng, Yanan, Department of Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China
Meng, Yaping, Northwest University for Nationalities, Lanzhou 730000, Gansu Province, China
S
Miao, Shimin
Miao, Shuhang , Xinghua City People’s Hospital, Xinghua 225700, Jiangsu Province, China
X
Miao, Xiaona, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China
Y
Miao, Yudi , Department of Hematology, Shaanxi Provincial People's Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , [1] Lu S, Yao J, Li S, et al., 2021, Two Cases of Acute Non-Lymphocytic Leukemia with PICALM-MLLT10 and Literature Review. Chongqing Medicine, 50(19): 3369–3374. [2] Gao W, Jiang M, Gao L, et al., 2021, Analysis of Factors Related to Treatment Failure of Acute Lymphoblastic Leukemia in Children. Chinese Journal of Experimental Hematology, 29(03): 661–668. [3] Bai D, Bai Y, Tian F, 2021, Expression and Significance of Long Non-Coding RNA Homeobox Gene A11 Antisense RNA in the Bone Marrow of Children with Acute Lymphoblastic Leukemia. Cancer Progress, 19(20): 2087–2090. [4] Cao X, Wei Z, Liu D, et al., 2021, Comparison of the Efficacy of Haplotype and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Acute T-Lymphoblastic Leukemia in Complete Remission. Chinese Journal of Hematology, 42(03): 210–216. [5] Cao X, Qiu L, Zhang J, et al., 2021, Clinical Analysis of 41 Cases of Relapsed Acute B Lymphocytic Leukemia After CART Sequential Secondary Allogeneic Hematopoietic Stem Cell Transplantation. Chinese Journal of Hematology, 42(04): 318–323. [6] Zhang L, 2021, Changes of Peripheral Blood T Lymphocyte Subsets in Acute Myeloid Leukemia and Its Clinical Significance. Capital Food and Medicine, 28(17): 20–21. [7] Wang D, Ding Y, Zhou G, et al., 2021, Expression and Clinical Significance of Programmed Death Molecule 1/Programmed Death-Ligand 1 in Childhood Acute Lymphoblastic Leukemia. Chinese Journal of Practical Pediatrics, 36(07): 525–528. [8] Wang X, Chang Y, Liu Y, et al., 2021, Comparison of the Prognostic Significance of Minimal Residual Disease in Patients with PH-Positive Acute B Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation by Multiparameter Flow Cytometry and Real-Time PCR. Chin J Hematology, 42(02): 116–123. [9] Wang Z, Li S, Sun Y, et al., 2021, Positive Minimal Residual Disease Indicates Poor Prognosis of Acute Lymphoblastic Leukemia Patients with Complete Remission 2 or Above Before Allogeneic Transplantation. Chinese Journal of Laboratory Medicine, 44(12): 1145–1152. [10] Peng Q, Zhu C, Liu G, et al., 2021, Study on the Expression Significance of QKI, OCT4 and Bcl-2 mRNA in Children with Acute Lymphoblastic Leukemia. Chinese Journal of Cancer Prevention and Treatment, 28(15): 1151–1156. [11] Li L, Wang M, Song Y, et al., 2021, Application Value of ALL Multi-Probe System in the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia. Experimental and Laboratory Medicine, 39(02): 374–376. [12] Zhang X, Wang L, Tang B, et al., 2020, Pretreatment of Unrelated Umbilical Cord Blood Transplantation Without Antithymocyte Globulin for the Treatment of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Follow-Up Evaluation of 306 Cases. Chinese Journal of Tissue Engineering Research, 24(31): 4986–4993. [13] Tang W, 2020, Analysis of the Relationship Between Adverse Reactions and Plasma Concentrations of High-Dose Methotrexate in the Treatment of Childhood Acute Lymphoblastic Leukemia. China Prescription Drugs, 18(12): 70–71. [14] Lv M, Jiang E, He Y, et al., 2020, Comparison of the Efficacy of Autologous and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Ph+ Acute Lymphoblastic Leukemia. Chinese Journal of Hematology, 41(05): 373–378. [15] Feng J, Zhang L, Cao X, et al., 2020, Treatment of Ph-Chromosome-Negative Adolescents and Young Adults with Acute Lymphoblastic Leukemia with a Similar Regimen for Children: A Single-Center Retrospective Study. Chinese Journal of Hematology, 41(05): 399–404.
R
Mijiti, Rehelaimu, Department of Cardiology, Tianjin Medical University General Hospital, Tianjin 300052, China
G
Min, Geng
L
Min, Liu
Min, Liu, Department of Critical Care Medicine, The First Clinical Medical College of China Three Gorges University & Yichang Central People’s Hospital, Yichang 433000, Hubei Province, China
C
Ming, Chen
X
Ming, Xu
M
Mirteimouri, Masuomeh, Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
S
Mirzaeian, Sara, Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
M
Mofrad, Malihe Hasanzadeh, Department of Gynecology and Obstetrics, Mashhad University of Medical Sciences, Mashhad, Iran
F
Mohd Said, Faridah, Department of Nursing, Faculty of Nursing, Lincoln University College (LUC), 47301 Petaling Jaya, Selangor, Malaysia
J
Mou, Jie, The Sixth People’s Hospital of Yibin, Yibin 644000, Sichuan Province, China
Y
Mou, Yikun
1651 - 1675 of 3346 items
<< < 62 63 64 65 66 67 68 69 70 71 > >>